Revolving door is a VERY polite term for Patrizia Cavazzoni's moves. Then again, she has a 25-year history of picking Big Pharma over vulnerable patients. She'll fit right in with Scott Gottlieb.

In the third quarter of 2025, the Company expects to present data from its ongoing Phase I/II studies of AMT-130 in support of a potential BLA submission. The update will include follow-up data on all ...

GAITHERSBURG, Md., Feb. 27, 2025 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical ...

In 2024 shipments of Zyn rose to 644m cans (of 15-20 nicotine pouches each), up by more than half from the year before. In ...

Despite this being the worst flu season in 15 years, President Donald Trump's administration has abruptly cancelled a ...

The cancelation comes as the United States is in the midst of a particularly severe flu season. So far, there have been 86 deaths in children and 19,000 deaths in adults this season, according to data ...

Alexandria Real Estate Equities' strong performance includes a 6% growth year-over-year and impressive leasing activity. See ...

Jim Jones, the former head of the FDA who resigned earlier this month, said the agency's layoffs show that the current administration is unserious.

Google on Tuesday received clearance from the U.S. Food and Drug Administration for the Pixel Watch 3's Loss of Pulse ...

Leadership in statistical programming is about more than managing deliverables—it’s about inspiring teams and exceeding ...

In the market for a microcurrent device? After two months of testing popular brands like ZIIP, FOREO, NuFACE and Therabody, ...

A progressive approach to drug approval would balance the reality of drug safety and efficacy research with the desire to get ...